Integrated Safety Summary of Tofacitinib in Psoriatic Arthritis Clinical Studies

被引：0
|
作者：
Burmester, Gerd R. [1 ]
FitzGerald, Oliver [2 ]
Winthrop, Kevin [3 ]
Azevedo, Valderilio F. [4 ]
Rigby, William F. C. [5 ]
Kanik, Keith S. [6 ]
Wang, Cunshan [6 ]
Biswas, Pinaki [7 ]
Jones, Thomas [8 ]
Menon, Sujatha [6 ]
Palmetto, Niki [7 ]
Rojo, Ricardo [6 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Fed Parana, Curitiba, Parana, Brazil
[5] Geisel Sch Med Dartmouth, Lebanon, NH USA
[6] Pfizer Inc, Groton, CT 06340 USA
[7] Pfizer Inc, New York, NY USA
[8] Pfizer Inc, Collegeville, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
616
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    [J]. Rheumatology and Therapy, 2023, 10 : 1255 - 1276
  • [42] Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim
    Gomez-Reino, Juan J.
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Hendrikx, Thijs
    Ports, William C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] Integrated Safety Analyses of Tofacitinib in Ulcerative Colitis Clinical Trials
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas V.
    Pedersen, Ronald D.
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S403 - S404
  • [44] INTEGRATED SAFETY ANALYSIS OF TOFACITINIB IN ANKYLOSING SPONDYLITIS CLINICAL TRIALS
    Deodhar, A.
    Akar, S.
    Curtis, J.
    Zorkany, B.
    Magrey, M.
    Wang, C.
    Wu, J.
    Makgoeng, S. B.
    Vranic, I.
    Menon, S.
    Fleishaker, D.
    Diehl, A.
    Fallon, L.
    Yndestad, A.
    Landewe, R. B. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 394 - 395
  • [45] INTEGRATED EFFICACY ANALYSIS OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Nash, P.
    Coates, L. C.
    Fleischmann, R.
    Papp, K. A.
    Gomez-Reino, J. J.
    Kanik, K. S.
    Wang, C.
    Wu, J.
    Hendrikx, T.
    Ports, W. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 951 - 952
  • [46] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim A.
    Jesus Gomez-Reino, Juan
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Menon, Sujatha
    Hendrikx, Thijs
    Ports, William C.
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 567 - 582
  • [47] TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTERSTUDY OF 87 PATIENTS IN CLINICAL PRACTICE
    Galindez, E.
    Prieto-Pena, D.
    Martin, J. L.
    Joven, B.
    Rusinovich, O.
    Almodovar, R.
    Alegre, J. J.
    Mendez, L.
    Sellas, A.
    Martinez, A.
    Garcia de Vicuna, R.
    Ventin, C.
    Gorostiza, I.
    Gonzalez-Gay, M. A.
    Blanco, R.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1243 - 1244
  • [48] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Peter Nash
    Laura C. Coates
    Roy Fleischmann
    Kim A. Papp
    Juan Jesus Gomez-Reino
    Keith S. Kanik
    Cunshan Wang
    Joseph Wu
    Sujatha Menon
    Thijs Hendrikx
    William C. Ports
    [J]. Rheumatology and Therapy, 2018, 5 : 567 - 582
  • [49] The Impact of Time Since First Diagnosis on the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis
    Nash, Peter
    Greenwald, Maria
    Lin, Liang-Hung
    Yu, Wei
    Estrella, Paul Santos
    Mundayat, Rajiv
    Graham, Daniela
    Veale, Douglas
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: Integrated Analysis of Psoriasis and Psoriatic Arthritis Clinical Trial Data
    Gordon, Kenneth
    Blauvelt, Andrew
    Bachelez, Herve
    Coates, Laura
    Kaplan, Blair
    Koetse, Willem
    Drogaris, Leonidas
    Sinvhal, Ranjeeta
    Papp, Kim A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2791 - 2793
12345